Treatment durability, satisfaction and quality of life in virologically suppressed <scp>HIV</scp> ‐1 people switching to doravirine: Results from the French study <scp>DoraVIH</scp>

Despite the absence of a control group and limited sample size, these real-world data support the effectiveness of switching to a doravirine-based regimen, with high durability and improved patient satisfaction.